here are 4 mass. biotechs making noise at the ash conference so far.

the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted... we value our readers and are committed to growing our community by encouraging you to add to the discussion..

"it's a very exciting time," klugman said. "this is exactly where we would like prenatal diagnosis to go -- to be able to act on it."...

the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..

"the drug must be administered at the right time point during development," he said.